Trabectedin derivative 2 (TFA)
Trabectedin derivative 2 TFA (compound PL-12) is a Trabectedin derivative that can be used for the study of cancer[1].
Product Specifications
UNSPSC
12352211
Target
Drug Derivative
Related Pathways
Others
Field of Research
Cancer
Purity
99.78
Solubility
DMSO : 100 mg/mL
Smiles
N#C[C@@H]([C@]1([H])CC2=CC(C)=C3OC)N([C@](CO4)([H])C5=C(OCO6)C6=C7C)[C@@]([C@@](N1C)([H])C2=C3O)([H])[C@@](SC[C@](C8=CC=C9N)(NCCC8=C9)C4=O)([H])C5=C7OC(C)=O.O=C(O)C(F)(F)F
Molecular Formula
C41H42F3N5O10S
Molecular Weight
853.86
References & Citations
[1]Bin Zou, et al. Antibody-drug conjugates comprising trabectedin and lurbinectedin derivatives. WO2024186264A1.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, sealed storage, away from moisture and light)
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-172664A/Trabectedin-derivative-2-TFA-SDS-MedChemExpress.pdf
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items